To take the next clinical translational step, the goal of the present study was to test the hypothesis that UTMC-mediated delivery of STAT3 decoy inhibits growth of human head and neck squamous cell carcinoma in vitro and in vivo. The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.